Novonesis launches termamyl prime for efficient brewing

Brewers worldwide are navigating a challenging landscape marked by stagnating beer volumes, rising energy costs, and increasing pressure on profitability. In this demanding market, breweries are seeking solutions that help them do more with the resources they already have.Global biosolutions company Novonesis has long supported the brewing industry through its Termamyl® biosolutions and is now introducing the next evolution in this journey: Termamyl® Prime.

With this launch, Novonesis is advancing solutions that support higher brewing gravity, creating new opportunities for customers to increase capacity, improve profitability, and reduce energy consumption. It reflects the company’s commitment to developing robust, thermostable enzymes that simplify brewing processes and enhance operational efficiency.

“Termamyl® Prime is a clear example of how customer needs are at the centre of our innovation. This solution supports brewers in navigating a challenging market and reflects our commitment to staying close to customers, now and in the future,” says Philip Söderberg, Head of Business Unit Beverages.

New features that enhance brewing efficiency

Termamyl® Prime introduces advanced capabilities for customers in the liquefaction segment and for breweries adopting high-gravity brewing.

Immediate performance improvement

Liquefaction is the stage where heat and enzymes convert grain starch into fermentable sugars for yeast during fermentation. Termamyl® Prime is designed to handle tough, climate-affected barley, helping brewers maintain consistent production and delivering an immediate performance lift.

Supporting high-gravity brewing

High-gravity brewing enables breweries to produce concentrated beer and dilute it to final strength, increasing output without new equipment. Termamyl® Prime performs reliably under these demanding conditions, helping breweries operate higher-gravity processes efficiently.